Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics
Article By:
BioMedReports
Read
Wednesday, October 22, 2014 5:42 PM EDT
U.S. stocks turned lower in afternoon trading on Wednesday, with major indexes erasing earlier gains as a shooting at the Canadian parliament unnerved investors and Boeing and Biogen sold off following results.
Tekmira And J&J’s Ebola Drugs Advance Towards Deployment In West Africa
Article By:
PropThink
Read
Wednesday, October 22, 2014 9:07 AM EDT
Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two distinct approaches to Ebola, a therapeutic and vaccine respectively, are advancing.
AGIO Reports Phase 1/2 Clinical Trial Of AG-221; PSTI Advances Its Second Major Cell Therapy Product Line
Article By:
BioMedReports
Read
Wednesday, October 22, 2014 3:24 AM EDT
Agios Pharmaceuticals announced the initiation of a Phase 1/2 multicenter study of AG-221 in patients with advanced solid tumors. Pluristem Therapeutics announced it has completed development of its second major product line.
Chart Of The Day - Agios Pharmaceuticals (AGIO)
Article By:
Jim Van Meerten
Read
Tuesday, October 21, 2014 11:19 PM EDT
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. Since the Trend Spotter signaled a buy on 8/18 the stock gained 70.27%.
In this article: AGIO
TransTech Digest: What Do You And The Energizer Bunny Have In Common?
Article By:
Patrick Cox
Read
Tuesday, October 21, 2014 7:00 PM EDT
While it would be a stretch to say that you run on lithium, you may stand to benefit greatly from it.
Inovio Pharmaceuticals: Partnerships Keep Rolling In
Article By:
Terry Chrisomalis
Read
Tuesday, October 21, 2014 1:32 PM EDT
Inovio Pharmaceuticals partners with MedImmune to create monoclonal antibodies against various infections.
With Latest Data, Investors Again Compare Synergy To The Billion-Dollar Ironwood Pharma
Northwest Biotherapeutics: A Variety Of Possibilities With The Future Of Immunotherapy Treatments
Article By:
Terry Chrisomalis
Read
Tuesday, October 21, 2014 10:18 AM EDT
Northwest Biotherapeutic's recent news suggests a great buying opportunity.
In this article: NWBO
Orexigen: How We Crushed This Stock Pick
Article By:
Manny Backus
Read
Tuesday, October 21, 2014 6:42 AM EDT
Finally the stock market and many individual names have started to move enough to create profits in a very short time frame.
In this article: OREX
AbbVie: Staying Bullish As The Company Hikes Its Dividend 16.7%
Article By:
Matt Schilling
Read
Tuesday, October 21, 2014 3:04 AM EDT
As AbbVie hikes its quarterly dividend, I wanted to take a closer look at the company and note several reasons as to why I'm staying bullish on the company's stock.
In this article: ABBV
NewLink Genetics Scores Big Partnership Deal With Roche
Article By:
Terry Chrisomalis
Read
Monday, October 20, 2014 10:10 AM EDT
NewLink Genetics to co-develop cancer drug with Roche. Great news for NewLink.
Anacor Pharmaceuticals - Chart Of The Day
Article By:
Jim Van Meerten
Read
Friday, October 17, 2014 6:20 PM EDT
Revenue is expected to decrease 15.30% this year but grow again by 28.20% next year.
In this article: ANAC